Amantadine
DrugBank ID: DB00915
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 50 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| juvenile onset Parkinson disease 19A | 0.9985 | DL |
| hereditary late onset Parkinson disease | 0.9985 | DL |
| X-linked parkinsonism-spasticity syndrome | 0.9956 | DL |
| Rasmussen subacute encephalitis | 0.9948 | DL |
| atypical juvenile parkinsonism | 0.9948 | DL |
| parkinsonian-pyramidal syndrome | 0.9942 | DL |
| transaldolase deficiency | 0.9927 | DL |
| myelitis | 0.9924 | DL |
| PLA2G6-associated neurodegeneration | 0.9923 | DL |
| fructose-1,6-bisphosphatase deficiency | 0.9897 | DL |
| hemiparkinsonism-hemiatrophy syndrome | 0.9877 | DL |
| early-onset parkinsonism-intellectual disability syndrome | 0.9829 | DL |
| Parkinson disease | 0.9805 | DL |
| paralysis agitans, juvenile, of Hunt | 0.9786 | DL |
| Lewy body dementia | 0.9783 | DL |
| X-linked intellectual disability-ataxia-apraxia syndrome | 0.9780 | DL |
| progressive supranuclear palsy-corticobasal syndrome | 0.9777 | DL |
| X-linked intellectual disability-cerebellar hypoplasia syndrome | 0.9695 | DL |
| CLCN4-related X-linked intellectual disability syndrome | 0.9692 | DL |
| X-linked spasticity-intellectual disability-epilepsy syndrome | 0.9691 | DL |
| X-linked intellectual disability-spastic quadriparesis syndrome | 0.9664 | DL |
| hydrocephaly-cerebellar agenesis syndrome | 0.9661 | DL |
| lissencephaly type 1 due to doublecortin gene mutation | 0.9648 | DL |
| intellectual disability, X-linked, syndromic | 0.9644 | DL |
| syndromic X-linked intellectual disability Chudley-Schwartz type | 0.9636 | DL |
| X-linked cerebral-cerebellar-coloboma syndrome syndrome | 0.9635 | DL |
| NAA10-related syndrome | 0.9634 | DL |
| Paganini-Miozzo syndrome | 0.9633 | DL |
| X-linked intellectual disability-hypotonia-movement disorder syndrome | 0.9631 | DL |
| X-linked intellectual disability, Stocco dos Santos type | 0.9627 | DL |
| multiple system atrophy, parkinsonian type | 0.9626 | DL |
| MED12-related intellectual disability syndrome | 0.9624 | DL |
| lethal infantile mitochondrial myopathy | 0.9619 | DL |
| intellectual developmental disorder, X-linked, syndromic, Hackmann-Di Donato type | 0.9619 | DL |
| Prieto syndrome | 0.9616 | DL |
| X-linked intellectual disability with hypopituitarism | 0.9606 | DL |
| Basilicata-Akhtar syndrome | 0.9605 | DL |
| holoprosencephaly 13, X-linked | 0.9603 | DL |
| X-linked intellectual disability-craniofacioskeletal syndrome | 0.9596 | DL |
| X-linked intellectual disability-precocious puberty-obesity syndrome | 0.9595 | DL |
| postencephalitic Parkinson disease | 0.9575 | DL |
| X-linked intellectual disability-acromegaly-hyperactivity syndrome | 0.9504 | DL |
| primary progressive freezing gait | 0.9494 | DL |
| parkinson disease, autosomal dominant | 0.9456 | DL |
| autosomal dominant striatal neurodegeneration type 1 | 0.9429 | DL |
| autosomal recessive Parkinson disease | 0.9076 | DL |
| blepharospasm | 0.9068 | DL |
| parkinsonism with dementia of Guadeloupe | 0.9015 | DL |
| febrile infection-related epilepsy syndrome | 0.8845 | DL |
| parkinsonian disorder | 0.8765 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.